Zymeworks BC Inc (ZYME) Implied Volatility Current

Tracking ZYME implied volatility helps you identify when options premiums on Zymeworks BC Inc are historically cheap or expensive, and where the best trades are hiding. Zymeworks BC Inc implied volatility reflects the market's expectation of future price movement: when ZYME IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Zymeworks BC Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ZYME, tracking metrics like ZYME IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ZYME signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; BeiGene, Ltd.; and Exelixis, Inc.

It also has licensing and research collaboration with LEO Pharma A/S to research, develop, and commercialize bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was incorporated in 2003 and is headquartered in Vancouver, Canada.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ZYME implied volatility sits today versus where it has been. Our scanner ranks Zymeworks BC Inc implied volatility against its historical range, surfaces extremes in ZYME IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Zymeworks BC Inc IV is rich or cheap — measure it, then act on it.